Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome: Results From Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Acute Kidney Injury and Myocardial Damage in Patients With Acute Coronary Syndrome (PRATO-ACS Study)

Study Questions:

What is the effect of high-dose rosuvastatin on contrast-induced acute kidney injury (CI-AKI) in patients with acute coronary syndrome (ACS)?